The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Adherence to oral migraine-preventive medications among patients with chronic migraine
Abstract
Background: Chronic migraine (CM) is a disabling disorder characterized by ≥15 headache days per month that has been shown to significantly reduce quality of life. Migraine-prevention guidelines recommend preventive medications as the standard of care for patients with frequent migraine. The aim of this study was to assess adherence to 14 commonly prescribed oral migraine-preventive medications (OMPMs) among patients with CM. Methods: Retrospective claims analysis of a US claim database (Truven MarketScan® Databases) was queried to identify patients who were at least 18 years old, diagnosed with CM, and initiated an OMPM (antidepressants, beta blockers, or anticonvulsants) between January 1, 2008 and September 30, 2012. Medication possession ratios (MPR) and proportion of days covered (PDC) were calculated for each patient. A cutoff of ≥80% was used to classify adherence. The odds of adherence between OMPMs were compared using logistic regression models. Results: Of the 75,870 patients identified with CM, 8688 met the inclusion/exclusion criteria. Adherence ranged between 26% to 29% at six months and 17% to 20% at 12 months depending on the calculation used to classify adherence (PDC and MPR, respectively). Adherence among the 14 OMPMs was similar except for amitriptyline, nortriptyline, gabapentin, and divalproex, which had significantly lower odds of adherence when compared to topiramate. Conclusion: Adherence to OMPMs is low among the US CM population at six months and worsens by 12 months.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The International Classification of Headache Disorders, 3rd edition (beta version)
Headache Classification Committee of the International Headache Society (IHS) (2013) · Cephalalgia · doi:10.1177/0333102413485658 · Cited by 8,229
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Migraine prevalence, disease burden, and the need for preventive therapy
Lipton, R. B., Bigal, M. E., Diamond, M., Freitag, F., Reed, M. L., & Stewart, W. F. (2007) · Neurology · doi:10.1212/01.wnl.0000252808.97649.21 · Cited by 2,337
Medication compliance and persistence: terminology and definitions
Cramer, J. A., Roy, A., Burrell, A., Fairchild, C. J., Fuldeore, M. J., Ollendorf, D. A., & Wong, P. K. (2008) · Value in Health · doi:10.1111/j.1524-4733.2007.00213.x · Cited by 2,220 · cited 4×
“North central 841 (21) 288 (23) 706 (20) 1835 (21)”
BackgroundInfluentialDiMatteo, M. R. (2004) · Medical Care · doi:10.1097/01.mlr.0000114908.90348.f9 · Cited by 2,169 · cited 3×
“Northeast 487 (12) 162 (13) 420 (12) 1069 (12)”
BackgroundPatient Adherence and Medical Treatment Outcomes: A Meta-Analysis
Robin DiMatteo, M., Giordani, P. J., Lepper, H. S., & Croghan, T. W. (2002) · Medical Care · doi:10.1097/00005650-200209000-00009 · Cited by 1,490
Silberstein, S. D., Holland, S., Freitag, F., Dodick, D. W., Argoff, C., & Ashman, E. (2012) · Neurology · doi:10.1212/wnl.0b013e3182535d20 · Cited by 897
Self-citationFarmer, K. C. (1999) · Clinical Therapeutics · doi:10.1016/s0149-2918(99)80026-5 · Cited by 889
Blumenfeld, A., Varon, S., Wilcox, T., Buse, D., Kawata, A., Manack, A., Goadsby, P., & Lipton, R. (2011) · Cephalalgia · doi:10.1177/0333102410381145 · Cited by 627 · cited 8×
“Comprehensive 187 (5) 75 (6) 140 (4) 402 (5)”
BackgroundResultInfluentialSelf-citationGood and poor adherence: optimal cut-point for adherence measures using administrative claims data.
Karve, S., Cleves, M. A., Helm, M., Hudson, T. J., West, D. S., & Martin, B. C. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903126833 · Cited by 620
Buse, D. C., Manack, A. N., Fanning, K. M., Serrano, D., Reed, M. L., Turkel, C. C., & Lipton, R. B. (2012) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2012.02223.x · Cited by 549 · cited 4×
“Missing 193 (5) 43 (3) 114 (3) 350 (4)”
BackgroundInfluentialComparing Adherence and Persistence Across 6 Chronic Medication Classes
Yeaw, J., Benner, J. S., Walt, J. G., Sian, S., & Smith, D. B. (2009) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2009.15.9.728 · Cited by 549
Chronic migraine in the population: Burden, diagnosis, and satisfaction with treatment
Bigal, M. E., Serrano, D., Reed, M., & Lipton, R. B. (2008) · Neurology · doi:10.1212/01.wnl.0000323925.29520.e7 · Cited by 490
Bloudek, L. M., Stokes, M., Buse, D. C., Wilcox, T. K., Lipton, R. B., Goadsby, P. J., Varon, S. F., Blumenfeld, A. M., Katsarava, Z., Pascual, J., et al. (2012) · The Journal of Headache and Pain · doi:10.1007/s10194-012-0460-7 · Cited by 339
Self-citationSystematic Review of Migraine Prophylaxis Adherence and Persistence
Hepp, Z., Bloudek, L. M., & Varon, S. F. (2014) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2014.20.1.22 · Cited by 333
Self-citationLantéri-Minet, M., Duru, G., Mudge, M., & Cottrell, S. (2011) · Cephalalgia · doi:10.1177/0333102411398400 · Cited by 303 · cited 5×
“Comprehensive 187 (5) 75 (6) 140 (4) 402 (5)”
BackgroundInfluentialStokes, M., Becker, W. J., Lipton, R. B., Sullivan, S. D., Wilcox, T. K., Wells, L., Manack, A., Proskorovsky, I., Gladstone, J., Buse, D. C., et al. (2011) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2011.01945.x · Cited by 258
Self-citationHazard, E., Munakata, J., Bigal, M. E., Rupnow, M. F. T., & Lipton, R. B. (2009) · Value in Health · doi:10.1111/j.1524-4733.2008.00404.x · Cited by 167
Sattler, E. L. P., Lee, J. S., & Perri, M. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0074-z · Cited by 127 · cited 1×
“Medication possession ratio (MPR) and proportion of days covered (PDC) are two well-cited calculations used to estimate adherence from claims (23,24).”
BackgroundAdherence with Migraine Prophylaxis in Clinical Practice
Berger, A., Bloudek, L. M., Varon, S. F., & Oster, G. (2012) · Pain Practice · doi:10.1111/j.1533-2500.2012.00530.x · Cited by 118
Self-citationA Critical Evaluation of the Methodology of the Literature on Medication Compliance
Nichol, M. B., Venturini, F., & Sung, J. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.18233 · Cited by 114
Prophylaxis of migraine: general principles and patient acceptance
D’Amico, D., Tepper, S. J., & D’Amico, D. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s3497 · Cited by 110
The Use of Migraine Preventive Medications Among Patients with and without Migraine Headaches
Lafata, J. E., Tunceli, O., Cerghet, M., Sharma, K., & Lipton, R. B. (2009) · Cephalalgia · doi:10.1111/j.1468-2982.2009.01909.x · Cited by 39
Tolerance and Loss of Beneficial Effect During Migraine Prophylaxis: Clinical Considerations
Loder, E., & Rizzoli, P. B. (2011) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2011.01986.x · Cited by 36
Rejection and Acceptance of Possible Side Effects of Migraine Prophylactic Drugs
Kowacs, P. A., Piovesan, É. J., & Tepper, S. J. (2009) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2009.01431.x · Cited by 33
Cited by
A Controlled Trial of Erenumab for Episodic Migraine
Goadsby, P. J., Reuter, U., Hallström, Y., Broessner, G., Bonner, J. H., Zhang, F., Sapra, S., Picard, H., Mikol, D. D., & Lenz, R. A. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1705848 · Cited by 928
Fremanezumab for the Preventive Treatment of Chronic Migraine
Silberstein, S. D., Dodick, D. W., Bigal, M. E., Yeung, P. P., Goadsby, P. J., Blankenbiller, T., Grozinski-Wolff, M., Yang, R., Ma, Y., & Aycardi, E. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709038 · Cited by 792
Self-citationAilani, J., Burch, R. C., Robbins, M. S., & the Board of Directors of the American Headache Society (2021) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.14153 · Cited by 766
Tepper, S., Ashina, M., Reuter, U., Brandes, J. L., Doležil, D., Silberstein, S., Winner, P., Leonardi, D., Mikol, D., & Lenz, R. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30083-2 · Cited by 722
Diagnosis and management of migraine in ten steps
Eigenbrodt, A. K., Ashina, H., Khan, S., Diener, H.-C., Mitsikostas, D. D., Sinclair, A. J., Pozo-Rosich, P., Martelletti, P., Ducros, A., Lantéri-Minet, M., et al. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00509-5 · Cited by 594
Metadata
- Authors
- Hepp, Z., Dodick, D. W., Varon, S. F., Gillard, P., Hansen, R. N., & Devine, E. B.
- Venue
- Cephalalgia
- Publisher
- SAGE Publications
- Published
- 2014-08-27
- Volume
- 35
- Issue
- 6
- Pages
- 478-488
- ISSN
- 0333-1024 (ISSN-L)
- 1468-2982
- OpenAlex
- W2004916007
- Cited by
- 433
- References
- 25
- FWCI
- 9.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.